Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy

被引：0
作者：
Kristin E. Rojas
Thais A. Fortes
Patrick I. Borgen
机构：
[1] Brooklyn Breast Cancer Program of Maimonides Medical Center,Department of Surgery
来源：
Breast Cancer Research and Treatment | 2019年 / 174卷
关键词：
Ductal carcinoma in situ; DCIS; Breast cancer; Breast cancer screening; Breast cancer genomic profiling; Oncotype DCIS; Oncotype Dx;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 313
页数：6
相关论文
共 50 条
  • [41] The natural history of ductal carcinoma in situ: development, validation, and estimated outcomes of the SimDCIS model
    Poelhekken, Keris
    Dorrius, Monique D.
    Dibden, Amanda
    Duffy, Stephen W.
    van der Vegt, Bert
    de Bock, Geertruida H.
    Greuter, Marcel J. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 211 (01) : 223 - 231
  • [42] Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
    Eileen Rakovitch
    Sharon Nofech-Mozes
    Steven A. Narod
    Wedad Hanna
    Deva Thiruchelvam
    Refik Saskin
    Carole Taylor
    Alan Tuck
    Sandip Sengupta
    Leela Elavathil
    Prashant A. Jani
    Susan J. Done
    Naomi Miller
    Bruce Youngson
    Iwa Kong
    Lawrence Paszat
    Breast Cancer Research and Treatment, 2013, 138 : 581 - 590
  • [43] Controversies over the role of radiation therapy for ductal carcinoma in situ
    Smith, Benjamin D.
    Smith, Grace L.
    Buchholz, Thomas A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 433 - 441
  • [44] Modeling the natural history of ductal carcinoma in situ based on population data
    Chootipongchaivat, Sarocha
    van Ravesteyn, Nicolien T.
    Li, Xiaoxue
    Huang, Hui
    Weedon-Fekjr, Harald
    Ryser, Marc D.
    Weaver, Donald L.
    Burnside, Elizabeth S.
    Heckman-Stoddard, Brandy M.
    de Koning, Harry J.
    Lee, Sandra J.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [45] The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast
    van la Parra, R. F. D.
    Ernst, M. F.
    Barneveld, P. C.
    Broekman, J. M.
    Rutten, M. J. C. M.
    Bosscha, K.
    EJSO, 2008, 34 (06): : 631 - 635
  • [46] Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)
    Cheung, Shan
    Booth, Mary E.
    Kearins, Olive
    Dodwell, David
    BREAST, 2014, 23 (06) : 807 - 811
  • [47] Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS)
    Price, Alison
    Schnabel, Freya
    Chun, Jennifer
    Kaplowitz, Elianna
    Goodgal, Jenny
    Guth, Amber
    Axelrod, Deborah
    Shapiro, Richard
    Mema, Eralda
    Moy, Linda
    Darvishian, Farbod
    Roses, Daniel
    BREAST JOURNAL, 2020, 26 (05) : 931 - 936
  • [48] Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS)
    Geradts, Joseph
    Groth, Jeffrey
    Wu, Yuan
    Jin, Genglin
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 447 - 459
  • [49] Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?
    Zaugg, K
    Bodis, S
    RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) : 95 - 99
  • [50] Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
    Karlsson, E.
    Sandelin, K.
    Appelgren, J.
    Zhou, W.
    Jirstrom, K.
    Bergh, J.
    Warnberg, F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (03) : 517 - 524
12345